Navigation Links
Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months
Date:10/22/2008

.68

Average Number of Common

Shares Outstanding during

Each Period - Basic 1,332,744 1,343,036 1,333,542 1,343,897

Diluted Earnings per

Share $0.84 $0.84 $2.56 $2.63

Average Number of Common

Shares Outstanding during

Each Period - Diluted 1,356,909 1,372,145 1,358,902 1,376,505

See Notes to Results of Operations.

Results of Operations - As Adjusted

Wyeth has prepared the following presentation of its results of operations for the three and nine months ended September 30, 2008 and 2007, adjusted to exclude charges, which are considered certain significant items during the 2008 and 2007 third quarter and first nine months.

The comparative results of operations - as adjusted are as follows:

(In thousands except per share amounts)

(UNAUDITED) - AS ADJUSTED

Three Months Ended Nine Months Ended

9/30/2008 9/30/2007 9/30/2008 9/30/2007

Net Revenue $5,829,582 $5,619,536 $17,485,589 $16,636,272

Cost of Goods Sold 1,528,702 1,506,381 4,661,083 4,439,890

Selling, General and

Administrative Expenses 1,569,629 1,664,801 4,922,217 4,844,341

Research and Development

Expenses 793,362 798,434 2,443,685 2,374,079

Interest (Income)

Expense, Net 12,953 (39,622) 4,182 (73,440)

Other (Income)

Expense, Net 101,878 (61,416) 18,371 (251,748)

Income before Income Taxes 1,823,058 1,750,958 5,436,051 5,303,150

Provision for Income Taxes 604,811 519,053 1,718,673 1,552,120

Net Income $1,
'/>"/>

SOURCE Wyeth
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Wyeth Wins Philadelphia Diet Drug Trial Involving Claim of PPH
2. Wyeth Announces Increase in Common Stock Dividend
3. Retrospective Analysis of Phase 3 Data Suggest Wyeths Investigational Compound Bazedoxifene/Conjugated Estrogens Comparable to Placebo on Incidence of Abnormal Mammograms
4. Wyeth Sets Webcast And Conference Call for 2008 Third Quarter Earnings
5. Cyprus and Ireland Add Wyeths 7-Valent Pneumococcal Conjugate Vaccine (PCV7) to Their National Immunisation Schedules
6. Wyeth Names Daniel J. McIntyre Vice President, Corporate Communications
7. Wyeth and Impax Announce Final Settlement of Effexor XR Patent Suit
8. Wyeths Motion to Overturn Punitive Damages Award Granted by Arkansas Court
9. Wyeth Announces Bernard Poussot Assumes Chairman of the Board Position
10. Wyeth Declares Common and Preferred Stock Dividends
11. Wyeth Pharmaceuticals Announces Organizational Change

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... , DURHAM, N.C., Nov. 27 /PRNewswire/ -...will initiate water-soluble carbon nanotube-based ...he water-soluble carbon nanotubes, which have func...tion with cancer drugs, was developed in partnersh...conjugated carbon nanotubes serves as a drug deliv...
(Date:11/25/2009)... , BOSTON, Nov. 25 Biot...N1 virus, genomic data from the 1918 pandemic thro...current H1N1 pandemic, today issued its latest bio... that the lethality of the H1N1 ("Swine Flu") viru...ng the virus,s current outbreak in the spring of 2...
(Date:11/25/2009)... , NEW YORK, Nov. 25 Re...h report is available in its catalogue: ,, Bra...13 ,, http://www.reportlinker.com/p0165503/Br...013.html ,, Brazil Bioethanol Market Analysis ...port provides detailed analysis and forecasts of t...
(Date:11/24/2009)... The New York investment bank...ASX:NEU) has agreed an AU$6.7 mil convertible note...tor. The private placement was arranged by KTA Cap...isor. , New York (PRWEB) ...stment bank KTA Capital, LLC ("KTA Capital&qu...
Breaking Biology Technology:North Carolina Based Cromoz Inc. Launches Carbon Nanotechnology for Target Drug Delivery System in Cancer Treatment in Hyderabad, India 2Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 10KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2
...2008 A,cross-disciplinary research team at the Un...that their microscopic drug research platform can,...ntial drugs., After researchers placed an enzyme ...nt within the human body, the enzyme performed as ... can proceed to the next,step--testing new drugs t...
...Biosciences,Inc. (Nasdaq: RDEA ) today announced ...on non-nucleoside reverse transcriptase inhibitors...Antiviral Research (ICAR).,Additionally, data on t...MEK) inhibitors, RDEA119 and RDEA436, will be pres...rch (AACR) annual meeting., The presentation det...
...es announced today that,it has received the GMP ce...aboratories. "Good Manufacturing Practice" is a bo...th by EU and US drug agencies. GMP compliance,ensu...medical devices are,pro­duced and quality-controll... compliance is the gold standard in quality assura...
Other Biology Technology:U-Md. Researchers Report Advance in Biological Microfactories for Drug Research 2U-Md. Researchers Report Advance in Biological Microfactories for Drug Research 3U-Md. Researchers Report Advance in Biological Microfactories for Drug Research 4Ardea to Present Data on HIV Non-Nucleoside Reverse Transcriptase Inhibitor and Two MEK Inhibitors at Upcoming Medical Conferences 2Ardea to Present Data on HIV Non-Nucleoside Reverse Transcriptase Inhibitor and Two MEK Inhibitors at Upcoming Medical Conferences 3Vela Laboratories Receives the GMP Certificate for Its Analytical and Quality Control Laboratories 2
(Date:11/25/2009)... stomach, may be used to boost resistance to, or s...School of Medicine researchers report in a study p...oscience . , Parkinson,s disease is caused by a ... midbrain known as the substantia nigra, which is ...uction of dopamine in late-stage Parkinson,s cause...
(Date:11/25/2009)... heart pumps some 250 million liters of blood thro...fibers of the heart have to be extremely durable. ...r, vice chair of the Department of Medicine III at...r. H. A. Katus), has discovered a protein that is ...ular unit, the sarcomere. In cooperation with othe...
(Date:11/24/2009)...s to understanding how sounds associated with Navy... or if they hear it at all. , The same type of ...es to detect flaws in the space shuttle,s behemoth...peek inside the giant head of a whale. The scans a...f a whale,s hearing anatomy using a breakthrough m...
Breaking Biology News(10 mins):Hormone ghrelin can boost resistance to Parkinson's disease 2New genetic cause of cardiac failure discovered 2Rocket science leads to new whale discovery 22009 National Ergonomics Conference Coming To Las Vegas In November 3B Features Strategies For Dealing With A Slow Economy 26amp 3B Aging Workforce I 58536 12009 National Ergonomics Conference Coming To Las Vegas In November 3B Features Strategies For Dealing With A Slow Economy 26amp 3B Aging Workforce I 58536 22009 National Ergonomics Conference Coming To Las Vegas In November 3B Features Strategies For Dealing With A Slow Economy 26amp 3B Aging Workforce I 58536 32009 National Ergonomics Conference Coming To Las Vegas In November 3B Features Strategies For Dealing With A Slow Economy 26amp 3B Aging Workforce I 58536 4Noteworthy Medical Systems Selected as a Preferred EHR Vendor for Arizonas PACeHR Purchasing 26amp 3B Assistance Collaborative 58531 1Noteworthy Medical Systems Selected as a Preferred EHR Vendor for Arizonas PACeHR Purchasing 26amp 3B Assistance Collaborative 58531 2Noteworthy Medical Systems Selected as a Preferred EHR Vendor for Arizonas PACeHR Purchasing 26amp 3B Assistance Collaborative 58531 3Nobelprize org Expands Channels and News Services for the 2009 Nobel Prize Announcements 14296 1Nobelprize org Expands Channels and News Services for the 2009 Nobel Prize Announcements 14296 2Nobelprize org Expands Channels and News Services for the 2009 Nobel Prize Announcements 14296 3
...ed that night blindness is a new clinical symptom ...ical Institute (HHMI) international research schol...Institute for Genetic Engineering and Molecular Bi...l Council of Scientific Research and Technology in...ividuals with the tropical disease can shut down a...
... engineer blood vessels within the tissue of previ...ed in significant improvement in heart function. ...rgans. , With heart disorders affecting individu...ity rates, there has been a need to develop new tr...n the field of tissue engineering is to produce bl...
...ancient genes, scientists have for the first time ...ntly "irreducibly complex" molecular system. , The...ssor of biology at the University of Oregon,s Cent...be published in the April 7 issue of SCIENCE. , H...mplex molecular systems ?those in which the functi...
Other Biology News:A case of mistaken molecular identity 2A case of mistaken molecular identity 3Evolution of 'irreducible complexity' explained 2
EGTA from Research Organics, Inc.
GSD-501 System Calibration Kit from Invitrogen
... 2.0 network client/server version of Freezerworks...le management workflow in high-volume labs and fac...s without the need to share sample information. ...owerPC (100MHz, PPC 601); 13 in monitor with 256 c...
...pliPhi 500 Amplification Kit, 500 reactions. Prepa...4-6 h.Generate microgram quantities of template DN...mplified DNA directly for cycle sequencing without...quid cultures, colonies, plaques, or purified circ...
Biology Products: